Mr. Speaker, let me inform Canadians and members of the House that six rapid tests have been authorized: bKIT Virus Finder from Hyris; BD Veritor system from Becton, Dickinson and Company; Abbott ID Now; Abbott Panbio; Xpert Xpress; and Sofia 2 SARS Antigen FIA from Diagnostic Hybrids. By the end of the year we expect delivery of 20.5 million Abbott Panbio antigen tests.
In the House of Commons on November 23rd, 2020. See this statement in context.